Immatics Corp - IMTX Net earnings per share for the last four quarters

Official company branding of Immatics Corp (IMTX)

A unique target identification platform creates a powerful defensive moat for Immatics N.V. (IMTX). The growth rate history of net income per share YoY ttm demonstrates current volatility, where -80.70 determines the latest valuation metric. The company relies on its own manufacturing plants in the US and laboratories in Germany, while the development of T-cell therapy concepts is funded through external capital and grants.

Immatics (IMTX) Earnings per share for the last twelve months: for the period 02/11/2024 - 11/16/2026

IMTX (Immatics): analytical breakdowns and indicator data

Initial company analysis:IMTX, Immatics Corp
Mass-produced product of immatics.com

The metric is calculated as the daily ratio of current annual net earnings per share to the value for the same period last year, allowing for the real-time tracking of value generation rates. By analyzing the year-over-year EPS dynamics over the last 12 months on the GURU.Markets platform, an investor can assess how the cancer immunotherapy partnerships of Immatics N.V. (IMTX) translate into the business's financial stability.

Direct competitors

Earnings per share for the trailing year IBRX (ImmunityBio)|IMCR: Net earnings per share (EPS TTM)|JANX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months arcusbio.com|Net earnings per share for the last 12 months zymeworks.com (ZYME)|Earnings per share for the last twelve months Tango Therapeutics Inc (TNGX)|Net earnings per share for the last 12 months Iovance IOVA|Xencor Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Compass Therapeutics Corp CMPX|REPL - Earnings per share for the last twelve months|LYEL (lyell.com) - Earnings per share for the last 12 months|Innate Pharma S.A (IPHA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Pyxis Oncology, Inc. (PYXS)|Net earnings per share for the last 12 months CGEN|IOBT - Net earnings per share for the trailing year|Net earnings per share for the last 12 months STRO (Sutro Bio)|Earnings per share for the last four quarters INKT|Net earnings per share (EPS TTM) HOWL (Werewolf Therapeutics)|Earnings per share for the trailing year IMMX|alxoncology.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year CUE (Cue Biopharma)|PDS Biotechnology Corp (PDSB) - Earnings per share for the last twelve months|Sonnet BioTherapeutics Holdings, Inc. - Earnings per share for the trailing year|MAIA (MAIABiotech.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Liminatus Pharma Inc.|Earnings per share for the last twelve months lavatherapeutics.com (LVTX)|NXTC: Earnings per one share for the last 12 months|Leap Therapeutics - Net earnings per share for the last 12 months|Intensity Tx (INTS) - Net earnings per one share for the last twelve months|SNSE - Earnings per share for the last twelve months|Theriva Biologics - Earnings per share for the last four quarters|Gritstone Bio (GRTS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Kineta, Inc. (KA)|Net earnings per share for the last 12 months NEXI|TSBX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) VCNX|HARP: Earnings per one share for the last 12 months